Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • Ask rapid questions using medical jargon (ischemia, necrotic tissue, perfusion). [undo]
  • Ignore the wound complaint and focus solely on blood glucose. [undo]
  • Give an immediate diagnosis without exploring the patient’s narrative. [undo]
  • Verify patient identity and obtain e-consent before starting. [undo]
  • Ακολουθώ τις συμβουλές του γιατρού, διότι η κατάστασή μου μπορεί να αποβεί μοιραία αν αφεθεί αναξέλεγτη. [undo]
  • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication [undo]
  • Privacy risk [undo]
  • Allow the family member to stay on screen without clarifying their role [undo]
  • BrainHQ Συναισθηματικός παράγοντας [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21091
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway